Market Cap (In USD)
144.25 Thousand
Revenue (In USD)
-
Net Income (In USD)
-21.23 Thousand
Avg. Volume
-
- Currency
- USD
- Country
- Financial Services
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-1.0E-4
- PE
- -
- EPS
- -
- Beta Value
- -13.247
- ISIN
- AIG7551X1080
- CUSIP
- -
- CIK
- 1278465
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Nicholas W. Baxter
- Employee Count
- -
- Website
- https://ir.rhinobiotech.com
- Ipo Date
- 2005-02-04
- Details
- Rhino Biotech Limited intends to develop plant and fungi derived nutraceuticals, and preventative and curative biopharmaceuticals. The company was formerly known as Eurasia Energy Limited and changed its name to Rhino Biotech Limited in September 2021. Rhino Biotech Limited was incorporated in 2003 and is based in South Hill, Anguilla.
More Stocks
-
BASBasilix Cert
BAS
-
DXIEFDXI Capital Corp.
DXIEF
-
NFTFFNFT Technologies Inc.
NFTFF
-
NOVIS
-
ALNXTNextedia S.A.
ALNXT
-
HEBA-BHeba Fastighets AB (publ)
HEBA-B
-
BTDR
-
048530iNtRON Biotechnology, Inc.
048530